Showing 6,601 - 6,620 results of 30,200 for search '(( i et decrease ) OR ( 50 ((((we decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 1.10s Refine Results
  1. 6601
  2. 6602
  3. 6603
  4. 6604
  5. 6605
  6. 6606
  7. 6607
  8. 6608
  9. 6609

    Discovery of Novel 3‑Phenylpiperidine Derivatives Targeting the β‑Catenin/B-Cell Lymphoma 9 Interaction as a Single Agent and in Combination with the Anti-PD‑1 Antibody for the Tre... by Hao Zhang (15339)

    Published 2023
    “…Among them, compound <b>41</b> showed the best IC<sub>50</sub> (0.72 μM) in a competitive fluorescence polarization assay and a <i>K</i><sub>D</sub> value of 0.26 μM for the β-catenin protein. …”
  10. 6610

    Discovery of Novel 3‑Phenylpiperidine Derivatives Targeting the β‑Catenin/B-Cell Lymphoma 9 Interaction as a Single Agent and in Combination with the Anti-PD‑1 Antibody for the Tre... by Hao Zhang (15339)

    Published 2023
    “…Among them, compound <b>41</b> showed the best IC<sub>50</sub> (0.72 μM) in a competitive fluorescence polarization assay and a <i>K</i><sub>D</sub> value of 0.26 μM for the β-catenin protein. …”
  11. 6611

    Discovery of Novel 3‑Phenylpiperidine Derivatives Targeting the β‑Catenin/B-Cell Lymphoma 9 Interaction as a Single Agent and in Combination with the Anti-PD‑1 Antibody for the Tre... by Hao Zhang (15339)

    Published 2023
    “…Among them, compound <b>41</b> showed the best IC<sub>50</sub> (0.72 μM) in a competitive fluorescence polarization assay and a <i>K</i><sub>D</sub> value of 0.26 μM for the β-catenin protein. …”
  12. 6612

    Discovery of Novel 3‑Phenylpiperidine Derivatives Targeting the β‑Catenin/B-Cell Lymphoma 9 Interaction as a Single Agent and in Combination with the Anti-PD‑1 Antibody for the Tre... by Hao Zhang (15339)

    Published 2023
    “…Among them, compound <b>41</b> showed the best IC<sub>50</sub> (0.72 μM) in a competitive fluorescence polarization assay and a <i>K</i><sub>D</sub> value of 0.26 μM for the β-catenin protein. …”
  13. 6613
  14. 6614
  15. 6615
  16. 6616

    Trade-Off for Better Balanced Nonlinear Optical Performance with Disordered Si in ZnGeP<sub>2</sub> by Shunda Yang (8086265)

    Published 2022
    “…Theoretical calculations with special quasirandom structures show that the NLO coefficient decreases gradually with increasing Si content, but the decrease is tiny in the 0–50% range and acute in the 50–100% range of Si. …”
  17. 6617

    Trade-Off for Better Balanced Nonlinear Optical Performance with Disordered Si in ZnGeP<sub>2</sub> by Shunda Yang (8086265)

    Published 2022
    “…Theoretical calculations with special quasirandom structures show that the NLO coefficient decreases gradually with increasing Si content, but the decrease is tiny in the 0–50% range and acute in the 50–100% range of Si. …”
  18. 6618

    Trade-Off for Better Balanced Nonlinear Optical Performance with Disordered Si in ZnGeP<sub>2</sub> by Shunda Yang (8086265)

    Published 2022
    “…Theoretical calculations with special quasirandom structures show that the NLO coefficient decreases gradually with increasing Si content, but the decrease is tiny in the 0–50% range and acute in the 50–100% range of Si. …”
  19. 6619

    Trade-Off for Better Balanced Nonlinear Optical Performance with Disordered Si in ZnGeP<sub>2</sub> by Shunda Yang (8086265)

    Published 2022
    “…Theoretical calculations with special quasirandom structures show that the NLO coefficient decreases gradually with increasing Si content, but the decrease is tiny in the 0–50% range and acute in the 50–100% range of Si. …”
  20. 6620

    Trade-Off for Better Balanced Nonlinear Optical Performance with Disordered Si in ZnGeP<sub>2</sub> by Shunda Yang (8086265)

    Published 2022
    “…Theoretical calculations with special quasirandom structures show that the NLO coefficient decreases gradually with increasing Si content, but the decrease is tiny in the 0–50% range and acute in the 50–100% range of Si. …”